Y2 Solution CO.,LTD

KSE 011690.KS

Y2 Solution CO.,LTD Operating Income Margin for the year ending December 31, 2023: 1.39%

Y2 Solution CO.,LTD Operating Income Margin is 1.39% for the year ending December 31, 2023, a -5.79% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Y2 Solution CO.,LTD Operating Income Margin for the year ending December 31, 2022 was 1.48%, a 133.15% change year over year.
  • Y2 Solution CO.,LTD Operating Income Margin for the year ending December 31, 2021 was -4.46%, a -15.26% change year over year.
  • Y2 Solution CO.,LTD Operating Income Margin for the year ending December 31, 2020 was -3.87%, a 17.80% change year over year.
  • Y2 Solution CO.,LTD Operating Income Margin for the year ending December 31, 2019 was -4.71%, a 76.70% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
KSE: 011690.KS

Y2 Solution CO.,LTD

Description

Y2 Solution CO.,LTD provides TV power supply and LED lighting services in South Korea. The company offers switching mode power supply (SMPS) module for displays used in LED TV, UHD TV, OLED TV, signage TV, etc.; and indoor and outdoor LED lighting. It also provides secondary battery cell testing systems; location-based visible light communication (VLC) systems, which provides guidance and marketing services based on location without using RF communication for shopping malls, electronic attendance-absence recording systems, indoor navigation, and Zigbee commissioning; and bi-direction VLC systems used in smart factory, hospital, RF communication error environment, etc. In addition, the company offers IoT VLC systems to smart farm, smart factory, home IoT, etc.; and high-speed VLC systems used in meeting room security system, data transmission security system, network segregate, etc. Further, it provides imports and sells petrochemical products; and develops drugs for epidermolysis bullosa, dry-amd, duchenne muscular dystrophy, and type 2 diabetes. The company was formerly known as Yuyang D&U Co., Ltd. The company was founded in 1976 and is headquartered in Hwaseong-si, South Korea.

Similar companies

ESTA.JK

PT Esta Multi Usaha Tbk

USD 0.00

3.30%

3397.T

TORIDOLL Holdings Corporation

USD 24.31

-0.09%

PURI.JK

PT Puri Global Sukses Tbk

USD 0.02

22.67%

StockViz Staff

February 4, 2025

Any question? Send us an email